Paper39199374
The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.
Żychowska J and 7 others. Biomolecules, 2024. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection. Papers, record 39199374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199374
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epigenesis, Genetic | Major topic |
| Hepacivirus | Major topic |
| Hepatitis C | Major topic |
| DNA Methylation | Major topic |
| Humans | |
| Carcinoma, Hepatocellular | |
| Liver Neoplasms | |
| Animals |
Source PubMed
References166
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,639,012 | Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37639012 | PubMed |
| 2 | 27,004,559 | HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T-cell development. | J Viral Hepat | 2016 | https://conductscience.org/library/papers/27004559 | PubMed |
| 3 | 12,551,851 | IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. | FASEB J | 2003 | https://conductscience.org/library/papers/12551851 | PubMed |
| 4 | 30,210,805 | HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function. | Cell Discov | 2018 | https://conductscience.org/library/papers/30210805 | PubMed |
| 5 | 29,669,594 | miRNAs regulate immune response and signaling during hepatitis C virus infection. | Eur J Med Res | 2018 | https://conductscience.org/library/papers/29669594 | PubMed |
| 6 | 25,152,984 | Promotor methylation: does it affect response to therapy in chronic hepatitis C (G4) or fibrosis? | Ann Hepatol | 2014 | https://conductscience.org/library/papers/25152984 | PubMed |
| 7 | 15,528,343 | Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. | J Immunol | 2004 | https://conductscience.org/library/papers/15528343 | PubMed |
| 8 | 17,320,507 | Chromatin modifications and their function. | Cell | 2007 | https://conductscience.org/library/papers/17320507 | PubMed |
| 9 | 32,869,873 | Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex. | Hepatology | 2021 | https://conductscience.org/library/papers/32869873 | PubMed |
| 10 | 26,540,467 | Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma. | Oncotarget | 2015 | https://conductscience.org/library/papers/26540467 | PubMed |
| 11 | 22,114,337 | Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. | J Virol | 2012 | https://conductscience.org/library/papers/22114337 | PubMed |
| 12 | 23,085,648 | Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. | J Hepatol | 2013 | https://conductscience.org/library/papers/23085648 | PubMed |
| 13 | 36,992,689 | Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/36992689 | PubMed |
| 14 | 31,097,476 | HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition. | Cancer Res | 2019 | https://conductscience.org/library/papers/31097476 | PubMed |
| 15 | 33,015,376 | Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients. | Biochem Biophys Rep | 2020 | https://conductscience.org/library/papers/33015376 | PubMed |
| 16 | 30,199,576 | A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6. | Hepatology | 2019 | https://conductscience.org/library/papers/30199576 | PubMed |
| 17 | 27,283,940 | Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication. | EMBO Rep | 2016 | https://conductscience.org/library/papers/27283940 | PubMed |
| 18 | 37,239,415 | Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37239415 | PubMed |
| 19 | 29,973,597 | microRNA-122 amplifies hepatitis C virus translation by shaping the structure of the internal ribosomal entry site. | Nat Commun | 2018 | https://conductscience.org/library/papers/29973597 | PubMed |
| 20 | 31,543,877 | Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. | Front Immunol | 2019 | https://conductscience.org/library/papers/31543877 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,828,159 | Therapeutic, preventive, and pathogenetic advances in viral hepatitis. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42828159 | PubMed |
| 41,023,586 | Genomic medicine in hepatology: mechanisms and liver treatment strategies. | Mol Med | 2025 | https://conductscience.org/library/papers/41023586 | PubMed |
| 40,589,575 | The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40589575 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39199374
GET https://conductscience.org/api/papers/v1/39199374/references?page=2